These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 7646823)
1. Prevention and management of extravasation of cytotoxic drugs. Bertelli G Drug Saf; 1995 Apr; 12(4):245-55. PubMed ID: 7646823 [TBL] [Abstract][Full Text] [Related]
14. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole. Ludwig CU; Stoll HR; Obrist R; Obrecht JP Eur J Cancer Clin Oncol; 1987 Mar; 23(3):327-9. PubMed ID: 3595692 [TBL] [Abstract][Full Text] [Related]
15. [Introduction of a clinical protocol for extravasation at the National Institute of Oncology, Budapest, Hungary]. Bartal A; Mátrai Z; Rosta A; Szûcs A Magy Onkol; 2011 Mar; 55(1):14-20. PubMed ID: 21617787 [TBL] [Abstract][Full Text] [Related]
16. Toxicity to topical dimethyl sulfoxide (DMSO) when used as an extravasation antidote. Creus N; Mateu J; Massó J; Codina C; Ribas J Pharm World Sci; 2002 Oct; 24(5):175-6. PubMed ID: 12426960 [TBL] [Abstract][Full Text] [Related]
17. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Tsavaris NB; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P Cancer Chemother Pharmacol; 1992; 30(4):330-3. PubMed ID: 1643703 [TBL] [Abstract][Full Text] [Related]
18. Extravasation of systemic hemato-oncological therapies. Ener RA; Meglathery SB; Styler M Ann Oncol; 2004 Jun; 15(6):858-62. PubMed ID: 15151940 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes. Elam EA; Dorr RT; Lagel KE; Pond GD Invest Radiol; 1991 Jan; 26(1):13-6. PubMed ID: 2022447 [TBL] [Abstract][Full Text] [Related]